For example, in soft tissue sarcomas, ALT was associated with decreased survival compared to patients with telomerase activation26,78–82, whereas in osteosarcomas, no difference in clinical outcomes was observed between ALT and telomerase-activated tumors77. Here, GPT is linked to soft tissue sarcoma.